Trial Profile
Efficacy Study of Metadoxine SR Formulation in ADHD Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Metadoxine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- Sponsors Alcobra
- 05 Jul 2011 Trial phase changed from III to I as reported by ClinicalTrials.gov.
- 30 Nov 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 30 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.